Evidence map›Paper›PMID 38994774›Full record

ArticleMolecular medicine reports2024

[Retracted] Protective effect of microRNA‑381 against inflammatory damage of endothelial cells during coronary heart disease by targeting CXCR4.

Yimin Li, Jin Huang, Hong Yan, Xiangyu Li, Chang Ding, Qian Wang, Zhiping Lu

Abstract readRetraction Notice
In one paragraph

Article in Molecular medicine reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yimin LiDepartment of Cardiology, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China.
Jin HuangDepartment of Cardiology, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China.
Hong YanInspection Center, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China.
Xiangyu LiDepartment of Cardiology, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China.
Chang DingDepartment of Cardiology, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China.
Qian WangDepartment of Cardiology, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China.
Zhiping LuDepartment of Cardiology, Nanjing Chest Hospital, Nanjing, Jiangsu 210029, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the certain of the cell proliferation assay data shown in Fig. 4C on p. 1444 were strikingly similar to data appearing in different form in another article written by different authors at different research institutes, which had already been submitted for publication [Shi N, Shan B, Song Y, Chu H and Qian L: Circular RNA circ‑PRKCI functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR‑3680‑3p in esophageal squamous cell carcinoma. J Cell Biochem 120: 10021‑10030, 2019]. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to

Indexed as

coronary heart diseasec-X-c chemokine receptor type 4endothelial cellsinflammationmicrorna-381

Identifiers

PMID38994774
PMCPMC11258606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.